{"id":"W4391173849","doi":"10.1161/circulationaha.123.066279","title":"Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation","year":2024,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; Esperion Therapeutics; Daiichi Sankyo Europe; Servier; Eisai; Medicines Company; ARCA Biopharma; Sanofi; Abiomed; Biosense Webster; Novo Nordisk; MyoKardia; Daiichi-Sankyo; Zora Biosciences; Intarcia Therapeutics; Boston Scientific Corporation; Alexion Pharmaceuticals; Brigham and Women's Hospital; Pfizer; Heart and Stroke Foundation of Canada; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Bayer HealthCare; Kowa Company; National Institutes of Health; Regeneron Pharmaceuticals; Abbott Laboratories","keywords":"Medicine; Interquartile range; Vitamin K antagonist; Body mass index; Atrial fibrillation; Stroke (engine); Internal medicine; Warfarin; Hazard ratio; Randomized controlled trial; Cardiology; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02465412,0.003433335,0.01602592,0.003292111,0.0006499788,0.003729771,0.001934942,0.002485865,0.00203076],"category_scores_gemma":[0.03411586,0.001672952,0.05165868,0.003362219,0.0008520595,0.001551515,0.001283362,0.002540432,0.0001915202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001304907,"about_ca_system_score_gemma":0.001224483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002544631,"about_ca_topic_score_gemma":0.004078514,"domain_scores_codex":[0.9795284,0.01393654,0.002973689,0.002116127,0.001046831,0.0003984026],"domain_scores_gemma":[0.9693524,0.02227914,0.004989874,0.001979113,0.0008909118,0.000508522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01725719,0.00004360851,0.009678455,0.008241937,0.9601879,0.00007020657,0.00002847153,0.001273712,0.00030442,0.0000538786,0.0002114605,0.002648808],"study_design_scores_gemma":[0.003383478,0.0005659783,0.006084489,0.0004994757,0.9878744,0.00006693119,0.00001917333,0.0007821092,0.0001561343,0.0002293241,0.0003179699,0.00002050169],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.308706,0.6787966,0.005447307,0.001500651,0.0009102284,0.0006738151,0.00250014,0.0002129699,0.001252267],"genre_scores_gemma":[0.9510373,0.04237347,0.003200747,0.0009519886,0.0003418277,0.0005800335,0.001140667,0.0000695377,0.0003045287],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02465412,"threshold_uncertainty_score":0.130385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1825746454861422,"score_gpt":0.4315287766228023,"score_spread":0.2489541311366601,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}